![]() |
市场调查报告书
商品编码
1691679
慢性病电疗法的创新与成长机会Innovations and Growth Opportunities in Electroceuticals for Chronic Diseases |
电疗法是一个快速发展的领域,它寻求新的和创新的解决方案来克服治疗各种疼痛和神经病变的挑战。这些领域的新兴技术正引起人们的极大兴趣,因为它们有可能彻底改变该领域,为电疗行业的技术开发人员创造有希望的产品开发机会。但这项技术创新面临非选择性、侵入性、开放回路、资料外洩风险等重大挑战。因此,新兴电医疗技术的大部分研发活动主要集中在将人工智慧融入穿戴式装置上。
随着非成瘾性、非鸦片类药物的个人化治疗方法的兴起,人们的治疗方法从传统反应性药物转向现代预防性电疗法。与药物相比,这些药物可以实现早期疗育和更长期的疾病控制。
本报告指出了电疗产业正在采用的超越传统医药和药物的新技术。脊髓刺激、週边神经刺激和经颅磁刺激分别被广泛用于治疗慢性疼痛和神经系统疾病,随着穿戴式电动医疗设备、封闭回路型神经调节和个人化等新兴概念的出现,本报告探讨了新兴技术在该行业的潜在优势和劣势。
Transforming Chronic Disease Management Through Advanced Neuromodulation Technologies
Electroceuticals is a rapidly growing field that is pursuing new and innovative solutions to overcome challenges in treating various pain and neurological disorders. Emerging technologies in these areas attract significant interest because of their potential to revolutionize the field, creating promising opportunities for technology developers in the electroceutical industry for product development. However, the innovations face significant challenges, including non-selectivity, invasiveness, open-loop, and risk of data breach. As a result, most R&D activities in emerging electroceutical technologies mainly focus on incorporating AI in wearables.
Questions this report answers: What are the emerging technologies gaining prominence in pain and neurological disorders management in the electroceutical space? What are the advantages and disadvantages driving R&D efforts in these modalities? Who are the major stakeholders targeting the adoption of these emerging modalities? What are the growth opportunities for electroceuticals in pain and neurological disorder management and the MedTech industry in the future?
With the rise in non-addictive, non-opioid-based personalized treatment approaches, there is an adoption shift from traditional reactive pharmaceuticals to modern preventative electroceuticals. Compared to pharmaceutical drugs, these have enabled early intervention and long-term disease management. The primary focus of the study is to identify the emerging technologies witnessing adoption across the electroceutical industry that will surpass conventional drugs and pharmaceuticals. Because of the wide adoption of Spinal Cord Stimulation, Peripheral Nerve Stimulation, and Transcranial Magnetic Stimulation for treating chronic pain and neurological conditions, respectively, and the emerging concepts of wearable electroceutical devices, closed-loop neuromodulation, and personalization, this study discusses the potential advantages and disadvantages of emerging technologies in the industry.